The First Affiliated Hospital of Air Force Military Medical University
Xi'an, Shaanxi, 710032, China
NCT Number: NCT07600125
This study is a multi-center, observational study. Participants scheduled for gastroscopy and colonoscopy will undergo an epidemiological assessment and provide a stool sample prior to endoscopy for qualitative FIT, quantitative FIT, and novel biomarker testing, followed by the endoscopic examination. After completion of the baseline endoscopic screening, all enrolled participants will undergo a 2-year follow-up. The primary endpoints of the study are sensitivity and specificity for the screening of gastrointestinal cancers.The aim of this study is to develop and evaluate the sensitivity and specificity of fecal multi-marker panels for the screening of gastrointestinal cancers.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Xi'an, Shaanxi, 710032, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Stool samples are collected from participants before endoscopy for qualitative FIT, quantitative FIT, and novel biomarker testing. The results are used to screen for gastrointestinal cancers.
Time frame: At the time of baseline endoscopic screening, approximately 2 weeks after stool sample collection.
Contact information is provided by the study sponsor or research team.
Xijing Hospital
Other
Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers: a Multi-center Prospective Observational Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07738939
Adenocarcinoma, Biliary Tract Cancer (BTC)
Los Angeles, California, United States
View Trial DetailsNCT06414122
Colonic Diseases, Colorectal Cancer
Cologne, North Rhine-Westphalia, Germany
View Trial DetailsNCT07714538
Adenocarcinoma, Adenocarcinoma Of Esophagus
Maidstone, Kent, United Kingdom
View Trial DetailsNCT07642323
Colonic Diseases, Colorectal Neoplasms
View Trial Details